Anti-anxiety drug as medical treatment for stuttering
By admin | Aug 15, 2007
Originally developed as an anti-anxiety drug, Pagoclone is becoming a more common treatment for stuttering. It blocks a chemical called dopamine in the brain. Research has suggested that people who stutter have an excess of dopamine in the area of the brain that controls speech timing.
It is estimated that over 3 million Americans stutter. Stuttering affects individuals of all ages but occurs most frequently in young children between the ages of 2 and 6 who are developing language.
